Evidence map›Paper›PMID 32282862›Full record

ArticlePLoS pathogens2020

Multiple Wolbachia strains provide comparative levels of protection against dengue virus infection in Aedes aegypti.

Heather A Flores, Jyotika Taneja de Bruyne, Tanya B O'Donnell, Vu Tuyet Nhu, Nguyen Thi Giang, Huynh Thi Xuan Trang, Huynh Thi Thuy Van, Vo Thi Long, Le Thi Dui, Huynh Le Anh Huy and 10 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed.

  1. Trial
  2. Article
  3. Strategies forOne health (Amsterdam, Netherlands) · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Horizons of the Future: Preparedness and Response.Current topics in microbiology and immunology · 2026
    Review
  9. Article
  10. Article
  11. Article
  12. ExploitingPathogens (Basel, Switzerland) · 2025
    Review
  13. The making of a dangerous vector: factors shaping the vector competence ofFrontiers in cellular and infection microbiology · 2025
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Introduction ofiScience · 2024
    Article
  20. AntiviralmBio · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Heather A FloresWorld Mosquito Program, Institute of Vector-Borne Disease, Monash University, Clayton, Victoria, Australia.ORCID 0000-0001-5003-7547
Jyotika Taneja de BruyneWorld Mosquito Program, Institute of Vector-Borne Disease, Monash University, Clayton, Victoria, Australia.
Tanya B O'DonnellWorld Mosquito Program, Institute of Vector-Borne Disease, Monash University, Clayton, Victoria, Australia.
Vu Tuyet NhuOxford University Clinical Research Unit, Hospital for Tropical Disease, Ho Chi Minh City, Vietnam.
Nguyen Thi GiangOxford University Clinical Research Unit, Hospital for Tropical Disease, Ho Chi Minh City, Vietnam.
Huynh Thi Xuan TrangOxford University Clinical Research Unit, Hospital for Tropical Disease, Ho Chi Minh City, Vietnam.
Huynh Thi Thuy VanOxford University Clinical Research Unit, Hospital for Tropical Disease, Ho Chi Minh City, Vietnam.
Vo Thi LongOxford University Clinical Research Unit, Hospital for Tropical Disease, Ho Chi Minh City, Vietnam.
Le Thi DuiOxford University Clinical Research Unit, Hospital for Tropical Disease, Ho Chi Minh City, Vietnam.
Huynh Le Anh HuyOxford University Clinical Research Unit, Hospital for Tropical Disease, Ho Chi Minh City, Vietnam.
Huynh Thi Le DuyenOxford University Clinical Research Unit, Hospital for Tropical Disease, Ho Chi Minh City, Vietnam.
Nguyen Thi Van ThuyOxford University Clinical Research Unit, Hospital for Tropical Disease, Ho Chi Minh City, Vietnam.ORCID 0000-0001-7298-5724
Nguyen Thanh PhongHospital for Tropical Diseases, Ho Chi Minh City, Vietnam.
Nguyen Van Vinh ChauHospital for Tropical Diseases, Ho Chi Minh City, Vietnam.ORCID 0000-0003-4668-1019
Duong Thi Hue KienOxford University Clinical Research Unit, Hospital for Tropical Disease, Ho Chi Minh City, Vietnam.
Tran Thuy ViOxford University Clinical Research Unit, Hospital for Tropical Disease, Ho Chi Minh City, Vietnam.
Bridget WillsOxford University Clinical Research Unit, Hospital for Tropical Disease, Ho Chi Minh City, Vietnam.ORCID 0000-0001-9086-8804
Scott L O'NeillWorld Mosquito Program, Institute of Vector-Borne Disease, Monash University, Clayton, Victoria, Australia.ORCID 0000-0002-4131-3615
Cameron P SimmonsWorld Mosquito Program, Institute of Vector-Borne Disease, Monash University, Clayton, Victoria, Australia.
Lauren B CarringtonOxford University Clinical Research Unit, Hospital for Tropical Disease, Ho Chi Minh City, Vietnam.ORCID 0000-0001-9273-7912

Funding

Wellcome TrustWellcome Trust 102591/Z/13/Z
6 · The paper itself

Abstract

The insect bacterium Wolbachia pipientis is being introgressed into Aedes aegypti populations as an intervention against the transmission of medically important arboviruses. Here we compare Ae. aegypti mosquitoes infected with wMelCS or wAlbB to the widely used wMel Wolbachia strain on an Australian nuclear genetic background for their susceptibility to infection by dengue virus (DENV) genotypes spanning all four serotypes. All Wolbachia-infected mosquitoes were more resistant to intrathoracic DENV challenge than their wildtype counterparts. Blocking of DENV replication was greatest by wMelCS. Conversely, wAlbB-infected mosquitoes were more susceptible to whole body infection than wMel and wMelCS. We extended these findings via mosquito oral feeding experiments, using viremic blood from 36 acute, hospitalised dengue cases in Vietnam, additionally including wMel and wildtype mosquitoes on a Vietnamese nuclear genetic background. As above, wAlbB was less effective at blocking DENV replication in the abdomen compared to wMel and wMelCS. The transmission potential of all Wolbachia-infected mosquito lines (measured by the presence/absence of infectious DENV in mosquito saliva) after 14 days, was significantly reduced compared to their wildtype counterparts, and lowest for wMelCS and wAlbB. These data support the use of wAlbB and wMelCS strains for introgression field trials and the biocontrol of DENV transmission. Furthermore, despite observing significant differences in transmission potential between wildtype mosquitoes from Australia and Vietnam, no difference was observed between wMel-infected mosquitoes from each background suggesting that Wolbachia may override any underlying variation in DENV transmission potential.

Indexed as

AedesAnimalsDengue VirusFemaleMaleMosquito VectorsPest Control, BiologicalVirus ReplicationWolbachia

Identifiers

PMID32282862
PMCPMC7179939

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.